Atrial fibrillation is the most common arrhythmia in the adult population, and its incidence and prevalence are still rising. Cardiac devices are widely used in clinical practice in the management of various rhythm disturbances and heart failure treatment. Many patients who receive a pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy also experience atrial fibrillation in the course of their life. Therefore, this review aims to describe the role of these devices in the treatment and prevention of atrial fibrillation in the device recipients. In addition, all these implantable devices also serve as permanent ECG (electrocardiogram) monitors, thus providing important information about the presence and characteristics of atrial fibrillation that may or may not be detected by the patient but can modify our therapeutical approach with regard to the stroke prevention.

2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Cardiology Motol University Hospital Prague Czech Republic

See more in PubMed

Haim M, Hoshen M, Reges O, Rabi Y, Balicer R, Leibowitz M. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc. 2015;4(01):e001486. PubMed PMC

Lau C P, Rushby J, Leigh-Jones M et al.Symptomatology and quality of life in patients with rate-responsive pacemakers: a double-blind, randomized, crossover study. Clin Cardiol. 1989;12(09):505–512. PubMed

Brignole M, Auricchio A, Baron-Esquivias G et al.2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) Eur Heart J. 2013;34(29):2281–2329. PubMed

van Campen L C, De Cock C C, Visser F C, Visser C A.The effect of rate responsive pacing in patients with angina pectoris on the extent of ischemia on 201-thallium exercise scintigraphy Pacing Clin Electrophysiol 200225(4 Pt 1):430–434. PubMed

Sweeney M O, Bank A J, Nsah E et al.Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med. 2007;357(10):1000–1008. PubMed

Wilkoff B L, Cook J R, Epstein A E et al.Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288(24):3115–3123. PubMed

Healey J S, Toff W D, Lamas G A et al.Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 2006;114(01):11–17. PubMed

Nielsen J C, Thomsen P EB, Højberg S et al.A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J. 2011;32(06):686–696. PubMed

Andersen H R, Nielsen J C, Thomsen P EBet al.Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome Lancet 1997350(9086):1210–1216. PubMed

Connolly S J, Kerr C R, Gent M et al.Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med. 2000;342(19):1385–1391. PubMed

Lamas G A, Orav E J, Stambler B S et al.Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med. 1998;338(16):1097–1104. PubMed

Lamas G A, Lee K L, Sweeney M O et al.Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002;346(24):1854–1862. PubMed

Toff W D, Camm A J, Skehan J D; United Kingdom Pacing and Cardiovascular Events Trial Investigators.Single-chamber versus dual-chamber pacing for high-grade atrioventricular block N Engl J Med 200535302145–155. PubMed

Sweeney M O, Hellkamp A S, Ellenbogen K A et al.Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107(23):2932–2937. PubMed

Khan N K, Goode K M, Cleland J G et al.Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail. 2007;9(05):491–501. PubMed

Khand A U, Rankin A C, Kaye G C, Cleland J G. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J. 2000;21(08):614–632. PubMed

Dickstein K, Bogale N, Priori S et al.The European cardiac resynchronization therapy survey. Eur Heart J. 2009;30(20):2450–2460. PubMed

Fein A S, Wang Y, Curtis J P, Masoudi F A, Varosy P D, Reynolds M R; National Cardiovascular Data Registry.Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry J Am Coll Cardiol 20105610766–773. PubMed PMC

Brignole M, Botto G, Mont L et al.Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J. 2011;32(19):2420–2429. PubMed

Leclercq C, Walker S, Linde C et al.Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J. 2002;23(22):1780–1787. PubMed

Kay G N, Ellenbogen K A, Giudici M et al.The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. J Interv Card Electrophysiol. 1998;2(02):121–135. PubMed

Wood M A, Brown-Mahoney C, Kay G N, Ellenbogen K A. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. Circulation. 2000;101(10):1138–1144. PubMed

Chatterjee N A, Upadhyay G A, Ellenbogen K A, McAlister F A, Choudhry N K, Singh J P. Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review. Circ Arrhythm Electrophysiol. 2012;5(01):68–76. PubMed

Wilton S B, Leung A A, Ghali W A, Faris P, Exner D V. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2011;8(07):1088–1094. PubMed

Linde C, Leclercq C, Rex S et al.Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40(01):111–118. PubMed

Doshi R N, Daoud E G, Fellows C et al.Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study) J Cardiovasc Electrophysiol. 2005;16(11):1160–1165. PubMed

Tang A S, Wells G A, Talajic M et al.Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363(25):2385–2395. PubMed

Upadhyay G A, Choudhry N K, Auricchio A, Ruskin J, Singh J P. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2008;52(15):1239–1246. PubMed

Wein S, Voskoboinik A, Wein L, Billah B, Krum H. Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York Heart Association class II, and narrow QRS heart failure patients. J Card Fail. 2010;16(05):432–438. PubMed

Hayes D L, Boehmer J P, Day J D et al.Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 2011;8(09):1469–1475. PubMed

Cheng A, Landman S R, Stadler R W. Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients. Circ Arrhythm Electrophysiol. 2012;5(05):884–888. PubMed

Gasparini M, Auricchio A, Regoli F et al.Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2006;48(04):734–743. PubMed

Ganesan A N, Brooks A G, Roberts-Thomson K C, Lau D H, Kalman J M, Sanders P. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol. 2012;59(08):719–726. PubMed

Ferreira A M, Adragão P, Cavaco D M et al.Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. Europace. 2008;10(07):809–815. PubMed

Khadjooi K, Foley P W, Chalil S et al.Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart. 2008;94(07):879–883. PubMed

Tolosana J M, Hernandez Madrid A, Brugada J et al.Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study) Am J Cardiol. 2008;102(04):444–449. PubMed

Brignole M, Menozzi C, Gianfranchi L et al.Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation. 1998;98(10):953–960. PubMed

Kerr A J, Williams M JA, Stewart R AH.Ventricular rate and beat-to-beat variation of stroke volume in atrial fibrillation Am J Cardiol 200187091116–1119., A9 PubMed

Albertsen A E, Nielsen J C, Poulsen S H et al.Biventricular pacing preserves left ventricular performance in patients with high-grade atrio-ventricular block: a randomized comparison with DDD(R) pacing in 50 consecutive patients. Europace. 2008;10(03):314–320. PubMed

Albertsen A E, Nielsen J C, Poulsen S H et al.DDD(R)-pacing, but not AAI(R)-pacing induces left ventricular desynchronization in patients with sick sinus syndrome: tissue-Doppler and 3D echocardiographic evaluation in a randomized controlled comparison. Europace. 2008;10(02):127–133. PubMed

Yu C M, Chan J Y, Zhang Q et al.Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med. 2009;361(22):2123–2134. PubMed

Tops L F, Schalij M J, Holman E R, van Erven L, van der Wall E E, Bax J J. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol. 2006;48(08):1642–1648. PubMed

Sweeney M O, Hellkamp A S. Heart failure during cardiac pacing. Circulation. 2006;113(17):2082–2088. PubMed

Brignole M, Gammage M, Puggioni E et al.Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation. Eur Heart J. 2005;26(07):712–722. PubMed

Orlov M V, Gardin J M, Slawsky M et al.Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. Am Heart J. 2010;159(02):264–270. PubMed

Kiès P, Leclercq C, Bleeker G B et al.Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart. 2006;92(04):490–494. PubMed PMC

Hauck M, Bauer A, Voss F, Katus H A, Becker R. Effect of cardiac resynchronization therapy on conversion of persistent atrial fibrillation to sinus rhythm. Clin Res Cardiol. 2009;98(03):189–194. PubMed

Hess P L, Jackson K P, Hasselblad V, Al-Khatib S M. Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis. Curr Cardiol Rep. 2013;15(02):330. PubMed PMC

Lellouche N, De Diego C, Vaseghi M et al.Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation. Pacing Clin Electrophysiol. 2007;30(11):1363–1368. PubMed

Gasparini M, Steinberg J S, Arshad A et al.Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. Eur Heart J. 2010;31(08):976–983. PubMed

Kalscheur M M, Saxon L A, Lee B K et al.Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial. Heart Rhythm. 2017;14(06):858–865. PubMed

Hügl B, Bruns H J, Unterberg-Buchwald C et al.Atrial fibrillation burden during the post-implant period after CRT using device-based diagnostics. J Cardiovasc Electrophysiol. 2006;17(08):813–817. PubMed

Yannopoulos D, Lurie K G, Sakaguchi S et al.Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure. J Am Coll Cardiol. 2007;50(13):1246–1251. PubMed

Kristensen L, Nielsen J C, Mortensen P T, Pedersen O L, Pedersen A K, Andersen H R. Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome. Heart. 2004;90(06):661–666. PubMed PMC

Cheng S, Keyes M J, Larson M G et al.Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA. 2009;301(24):2571–2577. PubMed PMC

Brandt N H, Kirkfeldt R E, Nielsen J C et al.Single lead atrial vs. dual chamber pacing in sick sinus syndrome: extended register-based follow-up in the DANPACE trial. Europace. 2017;19(12):1981–1987. PubMed

Tse H F, Lau C P, Ayers G M. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart. 1999;82(03):319–324. PubMed PMC

Ward K J, Willett J E, Bucknall C, Gill J S, Kamalvand K. Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment. Europace. 2001;3(02):108–114. PubMed

Yu W C, Chen S A, Tai C T, Feng A N, Chang M S. Effects of different atrial pacing modes on atrial electrophysiology: implicating the mechanism of biatrial pacing in prevention of atrial fibrillation. Circulation. 1997;96(09):2992–2996. PubMed

Bailin S J, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol. 2001;12(08):912–917. PubMed

Padeletti L, Pieragnoli P, Ciapetti C et al.Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J. 2001;142(06):1047–1055. PubMed

D'Allonnes G R, Pavin D, Leclercq C et al.Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: a nine-year experience. J Cardiovasc Electrophysiol. 2000;11(10):1081–1091. PubMed

Attuel P, Pellerin D, Mugica J, Coumel P.DDD pacing: an effective treatment modality for recurrent atrial arrhythmias Pacing Clin Electrophysiol 198811(11 Pt 2):1647–1654. PubMed

Fung J W, Yu C M, Chan J Y et al.Effects of cardiac resynchronization therapy on incidence of atrial fibrillation in patients with poor left ventricular systolic function. Am J Cardiol. 2005;96(05):728–731. PubMed

D'Ascia S L, D'Ascia C, Marino V et al.Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy. Int J Clin Pract. 2011;65(11):1149–1155. PubMed

Buck S, Rienstra M, Maass A H, Nieuwland W, Van Veldhuisen D J, Van Gelder I C. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time. Europace. 2008;10(05):558–565. PubMed

Brenyo A, Link M S, Barsheshet A et al.Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) J Am Coll Cardiol. 2011;58(16):1682–1689. PubMed

Hoppe U C, Casares J M, Eiskjaer H et al.Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation. 2006;114(01):18–25. PubMed

Borleffs C J, van Rees J B, van Welsenes G H et al.Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55(09):879–885. PubMed

Turco P, D'Onofrio A, Stabile Get al.Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation J Interv Card Electrophysiol 20123503331–336., discussion 336 PubMed

Sunman H, Aytemir K, Yorgun H et al.Evaluating the efficacy and safety of internal cardioversion with implantable cardioverter defibrillator device for atrial fibrillation in systolic heart failure patients. Ann Noninvasive Electrocardiol. 2016;21(02):181–188. PubMed PMC

Kirchhof P, Benussi S, Kotecha D et al.2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962. PubMed

Reddy V Y, Doshi S K, Sievert H et al.Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial. Circulation. 2013;127(06):720–729. PubMed

Holmes D R, Jr, Kar S, Price M J et al.Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(01):1–12. PubMed

Bajaj N S, Parashar A, Agarwal S et al.Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies. JACC Cardiovasc Interv. 2014;7(03):296–304. PubMed

Boersma L V, Schmidt B, Betts T R et al.Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016;37(31):2465–2474. PubMed PMC

Dukkipati S R, Kar S, Holmes D R et al.Device-related thrombus after left atrial appendage closure. Circulation. 2018;138(09):874–885. PubMed